Skip to content
ppharmaranks
Menu

Best Alkylating Drug for adenocarcinoma

4 Alkylating Drug drugs used for adenocarcinoma, ranked by our independent rating. Compare them with all treatments for adenocarcinoma or the full Alkylating Drug class. Not medical advice — always consult a professional.

Quick answer: Of the 4 alkylating drug drugs we rate for adenocarcinoma, none are yet flagged as generics in our price data, and most are injectable. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for adenocarcinoma; the right choice depends on your situation, so confirm it with your prescriber.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

How alkylating drug work

Alkylating chemotherapy drugs attach chemical groups to a cell's DNA, forming cross-links that lock the two DNA strands together. This damage stops the cell from copying its DNA and dividing, which triggers it to die; because they are not limited to one phase of the cell cycle, they can act on cells whether or not they are actively dividing.

Source: Cyclophosphamide — StatPearls, NCBI Bookshelf (NIH)

Top alkylating drug for adenocarcinoma: 1. Mitomycin · 2. Mitosol · 3. Tepylute

Best-rated Alkylating Drug for adenocarcinoma, ranked by pharmaranks score
#DrugRatingPharmacy pays
1Not yet ratedView →
2Not yet ratedView →
3Not yet ratedView →
4Not yet ratedView →

Full ranking · 4 drugs

Frequently asked

What is the best alkylating drug for adenocarcinoma?
Ratings are based on FDA regulatory recall-safety data — always consult a professional.
Which alkylating drug drugs treat adenocarcinoma?
pharmaranks lists 4 Alkylating Drug products used for adenocarcinoma, per NIH RxClass drug-classification data — each independently rated and ranked above.
How are these ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.